本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

24.03
+1.999.03%
盤後:24.500.4700+1.96%19:39 EDT
成交量:369.15萬
成交額:8,692.11萬
市值:27.00億
市盈率:-14.11
高:24.54
開:23.19
低:22.23
收:22.04
52周最高:28.11
52周最低:15.96
股本:1.12億
流通股本:9,711.04萬
量比:3.95
換手率:3.80%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
淨資產收益率:-26.91%
總資產收益率:-14.75%
市淨率:4.45
市盈率(LYR):-14.99

資料載入中...

2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities